Project News

This section keeps you updated on any major developments throughout the course of the A-TANGO project. For A-TANGO info brochures (in various languages), press releases, posters, and more, please visit the Downloads page. To receive our half-yearly newsletter, subscribe here!

  • 30 November 2021

    A-TANGO info brochure now available in 4 more languages

    The A-TANGO info brochure is now available in 4 more languages (DE, ES, FR, NL), each in a print + web version. Feel free to download, print, and share! We are getting ready for the G-TAK study to treat ACLF, occurring in late-stage cirrhosis, and will use the info brochure to inform patients participating in the study, as well as their relatives, about the bigger scope of the A-TANGO project. A big thank you goes out to the volunteer translators within the consortium!

  • 20 September 2021

    Successful 2nd GA Meeting

    Congrats to all work package leaders for the great progress made on their tasks, and for the detailed updates and presentations during the 2nd Steering Committee (SC) Meeting on 20 September 2021. The preparations for getting 30 European liver centres on board, receiving all necessary ethics approvals, and setting up the clinical trial (including manufacturing the drugs for the combinatorial G-TAK therapy) are at full speed. Although we had lots of fun on Zoom, we still can’t wait to meet in person soon. Hopefully, for the 2nd General Assembly (GA) meeting next year!

  • 2 September 2021

    Cornelius Engelmann introduces A-TANGO on YouTube

    Watch this introductory video about A-TANGO. It is a recording of a joint patient event that informed the liver patient community in Europe about A-TANGO and two related Horizon 2020-funded cirrhosis projects, namely DECISION and MICROB-PREDICT. At the beginning of the video, the project’s scientific coordinator, Prof. Dr. Rajiv Jalan, emphasises the urgent need of novel therapies for late-stage cirrhosis, before the clinical study supervisor, Dr. Cornelius Engelmann, explains the details of the new combinatorial therapy ‘G-TAK’ that A-TANGO tests.

  • 27 August 2021

    Invitation to join the Liver Health Helix

    The ‘Helix’ will form a community hub of peers that allows you to collaborate and also follow the A-TANGO project’s progress, activities, and results. Within the Helix, you can share and join specific collaboration opportunities related to cirrhosis, ACLF, and liver health. You can also invite stakeholders outside of the network who may be interested in this field. Join the Liver Health Helix and click “Follow”. You will then be notified of new opportunities according to your chosen interests.

  • 30 June 2021

    Stakeholder Map & Dissemination Plan ready

    We have developed both the “Stakeholder Map” (D7.1) as well as the Dissemination & Communication Plan” (D7.2), outlining in detail the communication strategy, responsibilities, and target release dates. The deliverable reports are confidential but available for download from the intranet for all project members.

  • 17 March 2021

    Successful Kick-off Meeting

    A-TANGO successfully kicked off in form of an online meeting on 17th March 2021. Consortium members outlined the work ahead over the next 12 months, elected the Impact Board (IB), made first decisions, and incorporated valuable feedback from the scientific and ethical advisory board (SEAB). A welcome break from all the science was a trivia quiz during a 10 min break in the afternoon!

  • 1 March 2021

    A-TANGO starts today

    On 1st March 2021, the 5-year long, pan-European research project begins. All of us are excited to roll up our sleeves and get to work! A total of eight work packages (WPs) will cover the entire value chain of research and development, from discovery to clinical validation and market preparation. We are looking forward to meet all project members at the virtual kick-off meeting on 17th March 2021.